Your browser doesn't support javascript.
loading
Risk Factors Associated With Unplanned Acute Care in Outpatient Chemotherapy With Oral Anticancer Drugs as Monotherapy or Combination Therapy With Injectable Anticancer Drugs.
Kawasumi, Kenji; Kawano, Yohei; Kujirai, Azusa; Mano, Yasunari; Matsui, Reiko; Maeda-Minami, Ayako; Yamamoto, Yuichiro; Negishi, Kenichi; Shimada, Shuji; Yamaguchi, Masakazu; Nagata, Masashi; Aoyama, Takao.
Afiliação
  • Kawasumi K; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Kawano Y; Department of Pharmacy, National Cancer Center Hospital East (NCCHE), Chiba, Japan.
  • Kujirai A; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan; yohei-kawano@rs.tus.ac.jp.
  • Mano Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Matsui R; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Maeda-Minami A; Department of Pharmacy, National Cancer Center Hospital East (NCCHE), Chiba, Japan.
  • Yamamoto Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Negishi K; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Shimada S; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Yamaguchi M; Faculty of Pharmaceutical Sciences, Tokyo University of Science (TUS), Chiba, Japan.
  • Nagata M; Department of Pharmacy, National Cancer Center Hospital (NCCH), Tokyo, Japan.
  • Aoyama T; Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Anticancer Res ; 41(11): 5827-5834, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34732458
BACKGROUND/AIM: Recently, the number of patients with cancer receiving outpatient chemotherapy using oral anticancer drugs has increased, but the currently available outpatient cancer chemotherapy is not safer than that available before. The present study aimed to identify risk factors associated with unplanned acute care (UAC) requiring outpatient chemotherapy-related consultation and hospitalisation. PATIENTS AND METHODS: We conducted a case- control study among 1,674 patients who received oral anticancer drug treatment either alone or in combination with injectable anticancer drugs at National Cancer Center Hospital East, Japan, between December 1, 2014, and November 30, 2015. RESULTS: Body mass index (BMI) was identified as a risk factor for UAC during chemotherapy. Patients with a BMI of <18.5 kg/m2, classified as underweight according to the World Health Organization classification of nutritional status, had a significantly higher risk of UAC. CONCLUSION: A low BMI immediately before the occurrence of chemotherapy-related UAC is a risk factor for adverse effects; therefore, underweight patients need more careful monitoring and supportive care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Assistência Ambulatorial / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Assistência Ambulatorial / Neoplasias Idioma: En Ano de publicação: 2021 Tipo de documento: Article